UC Davis Comprehensive Cancer Center http://www.ucdmc.ucdavis.edu/publish/rss/{$key} UC Davis Comprehensive Cancer Center news UC Davis Comprehensive Cancer Center http://www.ucdmc.ucdavis.edu/global/images/wordmarks/cancer_center.gif http://www.ucdmc.ucdavis.edu/publish/rss/cancercenter UC Davis Comprehensive Cancer Center news Pushing past cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9261/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9261 SACRAMENTO, Calif. (September 18, 2014) - Special event targeting young cancer survivors ages 15-39 to be held on Nov. 8, 2014 at the UC Davis Comprehensive Cancer Center, 2279 45th St., Sacramento from 10 a.m. to 4:30 p.m. Thu, 18 Sep 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9261 Susan Mar 2014-09-18T00:00:00Z UC Davis to recognize Breast Reconstruction Awareness (BRA) Day on Oct. 15 http://www.ucdmc.ucdavis.edu/publish/news/cancer/9266/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9266 SACRAMENTO, Calif. (September 18, 2014) - The UC Davis Comprehensive Cancer Center is sponsoring a day of interactive, informative event to recognize the brave face of each woman with breast cancer on Oct. 15, 2014 from 11 a.m. to 2 p.m. at the cancer center, 4501 X St., Sacramento. Thu, 18 Sep 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9266 Susan Mar 2014-09-18T00:00:00Z UC Davis-developed target leukemia treatment shows promise http://www.ucdmc.ucdavis.edu/publish/news/cancer/9243/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9243 SACRAMENTO, Calif. (September 11, 2014) - Noriko Satake, UC Davis pediatric oncologist and researcher, has demonstrated in laboratory studies that a new, targeted treatment for leukemia is effective. Thu, 11 Sep 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9243 Susan Mar 2014-09-11T00:00:00Z Introducing the multi-tasking nanoparticle http://www.ucdmc.ucdavis.edu/publish/news/cancer/9051/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9051 SACRAMENTO, Calif. (August 26, 2014) - mKit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles can be used as contrast agents to light up tumors for MRI and PET scans or deliver chemo and other therapies to destroy tumors. In addition, the particles are biocompatible and have shown no toxicity. The study was published online today in Nature Communications. Tue, 26 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9051 Dorsey Griffith 2014-08-26T00:00:00Z California isn't measuring up in the fight against cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9193/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9193 SACRAMENTO, Calif. (August 21, 2014) - In a media briefing at the UC Davis Comprehensive Cancer Center, the American Cancer Society Cancer Action Network released How Do You Measure Up?, an annual report that scores each state on how they are doing in the fight against cancer. Thu, 21 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9193 Susan Mar 2014-08-21T00:00:00Z Novel drug action against solid tumors explained http://www.ucdmc.ucdavis.edu/publish/news/cancer/9171/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9171 SACRAMENTO, Calif. (August 11, 2014) - Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells. Mon, 11 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9171 Susan Mar 2014-08-11T00:00:00Z Pan awarded grant to test 'smart' chemotherapy drug for bladder cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9168/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9168 SACRAMENTO, Calif. (August 7, 2014) - UC Davis Comprehensive Cancer Center oncologist Chong-Xian Pan has received a $650,000 grant from the VA Northern California Health Care System to conduct the first clinical trial of a novel chemotherapy-delivery drug he developed for bladder cancer patients. Thu, 07 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9168 Susan Mar 2014-08-07T00:00:00Z UC Davis researcher receives NSFC grant to find new gastric cancer genes http://www.ucdmc.ucdavis.edu/publish/news/cancer/9120/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9120 SACRAMENTO, Calif. (July 18, 2014) - No Stomach for Cancer Foundation (NSFC) has awarded cancer geneticist Luis Carvajal-Carmona a $50,000 grant to study the genetic characteristics of gastric cancer. Fri, 18 Jul 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9120 Susan Mar 2014-07-18T00:00:00Z Neural stem cell discovery may aid in treatment research for deafness http://www.ucdmc.ucdavis.edu/publish/news/cancer/9106/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9106 SACRAMENTO, Calif. (July 15, 2014) - Researchers at UC Davis School of Medicine have for the first time shown that a polysialylated glycoprotein that regulates neurodevelopment exists on the surface of cells in the adult inner ear. Tue, 15 Jul 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9106 Susan Mar 2014-07-15T00:00:00Z New combination drug controls tumor growth and metastasis in mice http://www.ucdmc.ucdavis.edu/publish/news/cancer/9105/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9105 SACRAMENTO, Calif. (July 14, 2014) - Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor’s ability to grow and spread. The study appears today in the journal Proceedings of the National Academy of Sciences. Mon, 14 Jul 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9105 Dorsey Griffith 2014-07-14T00:00:00Z Pancreatic surgery complications impact hospital costs more than length of stay http://www.ucdmc.ucdavis.edu/publish/news/cancer/8695/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8695 SACRAMENTO, Calif. (July 10, 2014) - When it comes to a specific type of pancreatic surgery, post-operative complications have a far greater impact on total cost than does how long the patient stays in the hospital, according to a published paper by UC Davis researchers. Thu, 10 Jul 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8695 Dorsey Griffith 2014-07-10T00:00:00Z Surgical biopsy proves safe for selected late-stage lung cancer patients http://www.ucdmc.ucdavis.edu/publish/news/cancer/9062/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9062 SACRAMENTO, Calif. (June 26, 2014) - Researchers at UC Davis have determined that surgical biopsies can be safely performed on select patients with late-stage non-small cell lung cancer, which should enhance their access to drugs that target specific genetic mutations such as epidermal growth factor receptor (EGFR). Thu, 26 Jun 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9062 Dorsey Griffith 2014-06-26T00:00:00Z Cancer Center's specialty pharmacy program helps patients adhere to oral chemotherapy http://www.ucdmc.ucdavis.edu/publish/news/cancer/9063/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9063 SACRAMENTO, Calif. (June 24, 2014) - A UC Davis program designed to better manage cancer patients taking oral chemotherapy drugs has demonstrated that one-on-one counseling, education and monitoring can improve adherence to potentially life-saving cancer treatments. Tue, 24 Jun 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9063 Dorsey Griffith 2014-06-24T00:00:00Z Groundbreaking lung cancer trial launched http://www.ucdmc.ucdavis.edu/publish/news/cancer/9043/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9043 SACRAMENTO, Calif. (June 16, 2014) - UC Davis Comprehensive Cancer Center patients will soon be part of an unprecedented clinical trial designed to improve access to promising therapies and speed development of effective treatments for an advanced form of lung cancer, the leading cancer killer of both men and women. Mon, 16 Jun 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9043 Susan Mar 2014-06-16T00:00:00Z UC Davis faculty share cancer research innovation with partners in Madrid http://www.ucdmc.ucdavis.edu/publish/news/cancer/9033/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9033 SACRAMENTO, Calif. (June 11, 2014) - UC Davis Comprehensive Cancer Center researchers take center stage this week in Madrid during the second in a series of workshops designed to enhance cultural, academic, scientific and business relations between UC Davis and Madrid. Wed, 11 Jun 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9033 Susan Mar 2014-06-11T00:00:00Z UC Davis professor selected to work with international team on cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/8990/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8990 SACRAMENTO, Calif. (May 29, 2014) - Paramita Ghosh, a UC Davis associate professor and expert in signal transduction pathways in prostate cancer, has been selected as one of 350 scientists to work on a project that aims to reduce public exposure to environmental agents that can lead to cancer and that hopes to inspire research into multi-faceted approaches to cancer prevention, treatment and prolonged survival. Thu, 29 May 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8990 Susan Mar 2014-05-29T00:00:00Z Tailored intervention has low impact on colorectal cancer screening http://www.ucdmc.ucdavis.edu/publish/news/cancer/8940/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8940 SACRAMENTO, Calif. (May 12, 2014) - Colorectal cancer screening saves lives, but too few people get tested. In an effort to increase these numbers,researchers from UC Davis and elsewhere investigated whether an individualized interactive multimedia computer program (IMCP) would spur patients to get screened. Mon, 12 May 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8940 Dorsey Griffith 2014-05-12T00:00:00Z Dual Role: Key cell division proteins also power up mitochondria http://www.ucdmc.ucdavis.edu/publish/news/cancer/8877/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8877 SACRAMENTO, Calif. (April 17, 2014) - An international team led by researchers at UC Davis has shown that the cyclin B1/Cdk1 protein complex, which plays a key role in cell division, also boosts the mitochondrial activity to power that process. This is the first time the complex has been shown to perform both jobs. This newfound ability could make cyclin B1/Cdk1 an excellent target to control cellular energy production, potentially advancing cancer care and regenerative medicine. The research was published online today in the journal Developmental Cell. Thu, 17 Apr 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8877 Dorsey Griffith 2014-04-17T00:00:00Z UC Davis personalizing outreach to address Asian cancer health disparities http://www.ucdmc.ucdavis.edu/publish/news/cancer/8860/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8860 SACRAMENTO, Calif. (April 11, 2014) - In an effort to reduce cancer health disparities among Asian-Americans, UC Davis Comprehensive Cancer Center now offers individual, in-language education and culturally sensitive materials for every Asian-American cancer patient. Fri, 11 Apr 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8860 Susan Mar 2014-04-11T00:00:00Z Time, trust and transparency keys to minority biospecimen collection http://www.ucdmc.ucdavis.edu/publish/news/cancer/8790/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8790 SACRAMENTO, Calif. (March 26, 2014) - Blood and tumor specimen collection from cancer patients is critical to research into new, more personally targeted therapies. But biospecimen collection among diverse populations lags far behind that of whites. [Chinese, Vietnamese and Spanish] Wed, 26 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8790 Dorsey Griffith 2014-03-26T00:00:00Z UC Davis physician featured in national health equity project http://www.ucdmc.ucdavis.edu/publish/news/cancer/8789/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8789 SACRAMENTO, Calif. (March 24, 2014) - UC Davis professor Christopher Bowlus of the Division of Gastroenterology and Hepatology, and his liver cancer disparity research, are featured on the Health Equity Research Snapshot of the Association of American Medical Colleges (AAMC). Mon, 24 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8789 Dorsey Griffith 2014-03-24T00:00:00Z Nine-year effort concludes to fund breast cancer endowment at UC Davis http://www.ucdmc.ucdavis.edu/publish/news/cancer/8787/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8787 SACRAMENTO, Calif. (March 21, 2014) - After nine years and countless fund-raising events, the Placer Breast Cancer Endowment on Thursday reached its goal of $1.5 million for breast cancer research at UC Davis Comprehensive Cancer Center. Fri, 21 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8787 Susan Mar 2014-03-21T00:00:00Z Potential lung cancer vaccine shows renewed promise http://www.ucdmc.ucdavis.edu/publish/news/cancer/8767/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8767 SACRAMENTO, Calif. (March 20, 2014) - Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The study also found that radiation treatments did not significantly impair the immune response. The paper was published on March 10 in the journal Cancer Immunology Research, an American Association for Cancer Research (AACR) publication. Thu, 20 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8767 Dorsey Griffith 2014-03-20T00:00:00Z UC Davis faculty drive efforts to improve CT safety http://www.ucdmc.ucdavis.edu/publish/news/cancer/8766/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8766 SACRAMENTO, Calif. (March 19, 2014) - UC Davis clinicians and physicists have recommended new strategies to make computed tomography (CT) safer, including adoption of a new metric for dose measurement, ways to manage exposure protocols that differ by CT brand and specific approaches to reduce exposure during needle biopsies. The recommendations are detailed in papers published in the March issue of the Journal of the American College of Radiology (JACR). Wed, 19 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8766 Dorsey Griffith 2014-03-19T00:00:00Z Minority clinical trials participation and analysis still lag 20 years after federal mandate http://www.ucdmc.ucdavis.edu/publish/news/cancer/8305/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8305 SACRAMENTO, Calif. (March 18, 2014) - Twenty years after Congress mandated that research funded by the National Institutes of Health include minorities, less than 5 percent of trials participants are non-white, and less than 2 percent of clinical cancer research studies focus on non-white ethnic or racial groups, UC Davis researchers have found. [Chinese, Spanish, Korean, Vietnamese] Tue, 18 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8305 Susan Mar 2014-03-18T00:00:00Z Joint cancer center study finds barriers to minority clinical trial participation http://www.ucdmc.ucdavis.edu/publish/news/cancer/8126/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8126 SACRAMENTO, Calif. (March 18, 2014) - A new study involving researchers from UC Davis and four other National Cancer Institute-designated cancer centers reveals important barriers that limit minority group participation in cancer clinical trials, findings that will be used to refine and launch more effective strategies to assure that more minorities benefit from clinical trials. Tue, 18 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8126 Susan Mar 2014-03-18T00:00:00Z UC Davis nursing school hopes to improve care for cancer patients with social network http://www.ucdmc.ucdavis.edu/publish/news/cancer/8756/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8756 SACRAMENTO, Calif. (March 14, 2014) - Several chemotherapy patients at the UC Davis Comprehensive Cancer Center will be invited to use tablets with a unique social networking tool as part of their treatment plan. Fri, 14 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8756 Susan Mar 2014-03-14T00:00:00Z UC Davis researchers one step closer to ovarian cancer marker http://www.ucdmc.ucdavis.edu/publish/news/cancer/8736/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8736 SACRAMENTO, Calif. (March 10, 2014) - The hunt is on to find biomarkers that detect cancer, but it’s a challenging process. Early successes often are followed by heartbreaking failures. Mon, 10 Mar 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8736 Susan Mar 2014-03-10T00:00:00Z Bone turnover markers predict prostate cancer outcomes http://www.ucdmc.ucdavis.edu/publish/news/cancer/8719/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8719 SACRAMENTO, Calif. (March 7, 2014) - Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found. Fri, 07 Mar 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/8719 Susan Mar 2014-03-07T00:00:00Z Bruce Hammock receives 2014 Brodie Award http://www.ucdmc.ucdavis.edu/publish/news/cancer/8602/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8602 SACRAMENTO, Calif. (January 23, 2014) - Bruce D. Hammock, UC Davis Distinguished Professor of Entomology, has received the 2014 Bernard B. Brodie Award from The American Society for Pharmacology and Experimental Therapeutics (ASPET). Thu, 23 Jan 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/8602 Susan Mar 2014-01-23T00:00:00Z James Purdy receives MD Anderson Distinguished Alumnus Award http://www.ucdmc.ucdavis.edu/publish/news/cancer/8601/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8601 SACRAMENTO, Calif. (January 23, 2014) - James A. Purdy, UC Davis professor emeritus in the UC Davis Department of Radiation Oncology, has been given the Distinguished Alumnus Award from the University of Texas MD Anderson Cancer Center. Thu, 23 Jan 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/8601 Susan Mar 2014-01-23T00:00:00Z Detecting gastric cancer early -- it's in the sugars http://www.ucdmc.ucdavis.edu/publish/news/cancer/8550/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8550 SACRAMENTO, Calif. (December 20, 2013) - Gastric cancer kills more than 700,000 people each year, mostly in Latin America, Asia and Eastern Europe. Though the disease is quite treatable when caught early, symptoms are indistinct and late detection leads to high mortality. The five-year survival rate in the United States is 26.9 percent. Fri, 20 Dec 2013 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/8550 Dorsey Griffith 2013-12-20T00:00:00Z Survival rates have not improved for metastatic prostate cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/8539/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8539 SACRAMENTO, Calif. (December 18, 2013) - Since the prostate specific antigen (PSA) test was introduced in the late 1980s, prostate cancer mortality has dropped by more than 40 percent. However, there has been tremendous controversy over whether the PSA test has caused that decline.  In a newly published study, UC Davis researchers suggest that PSA screening likely plays an important role. [en español]    Wed, 18 Dec 2013 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/8539 Dorsey Griffith 2013-12-18T00:00:00Z Hybrid clotting factor means fewer injections, better disease control for hemophilia patients http://www.ucdmc.ucdavis.edu/publish/news/cancer/8533/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8533 SACRAMENTO, Calif. (December 12, 2013) - A Phase III clinical trial led by UC Davis researchers has confirmed that a new coagulation factor (rFIXFc) dramatically reduces the number of injections needed to maintain effective clotting for hemophilia B patients. Thu, 12 Dec 2013 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/8533 Susan Mar 2013-12-12T00:00:00Z Better guidelines, coordination needed for prostate cancer specialists http://www.ucdmc.ucdavis.edu/publish/news/cancer/8331/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8331 SACRAMENTO, Calif. (December 9, 2013) - With a deluge of promising new drug treatments for advanced prostate cancer on the market, a new model of care is needed that emphasizes collaboration between urologists and medical oncologists, according to UC Davis prostate cancer experts. [en español] Mon, 09 Dec 2013 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/8331 Susan Mar 2013-12-09T00:00:00Z Health insurance increases preventive care but not risky behaviors http://www.ucdmc.ucdavis.edu/publish/news/cancer/8472/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8472 SACRAMENTO, Calif. (November 22, 2013) - People with health insurance are more likely to use preventive services such as flu shots and health screenings to reduce their risk of serious illness, but they are no more likely than people without health insurance to engage in risky health behaviors such as smoking or gaining weight, researchers at UC Davis and University of Rochester have found. [en español] Fri, 22 Nov 2013 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/8472 Karen Finney 2013-11-22T00:00:00Z Endocrine surgeon brings new expertise to UC Davis http://www.ucdmc.ucdavis.edu/publish/news/cancer/8349/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8349 SACRAMENTO, Calif. (October 23, 2013) - Michael Campbell recently joined UC Davis Health System as its first fellowship-trained endocrine surgeon. Campbell specializes in the evaluation and management of patients with thyroid, parathyroid, adrenal and pancreas disorders. Wed, 23 Oct 2013 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8349 Susan Mar 2013-10-23T00:00:00Z Ralph de Vere White wins lifetime achievement honor http://www.ucdmc.ucdavis.edu/publish/news/cancer/8338/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8338 SACRAMENTO, Calif. (October 21, 2013) - Ralph de Vere White, associate dean for cancer programs at UC Davis School of Medicine, director of the UC Davis Comprehensive Cancer Center and a distinguished professor of urology, has received the Huggins Medal Award from the Society of Urologic Oncology (SUO). Mon, 21 Oct 2013 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8338 Susan Mar 2013-10-21T00:00:00Z Record-breaking year for student support and alumni giving http://www.ucdmc.ucdavis.edu/publish/news/cancer/8264/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8264 SACRAMENTO, Calif. (October 2, 2013) - Nearly 40,000 donors committed $149.1 million to UC Davis during the 2012-13 fiscal year, surpassing the previous year’s total of $132.4 million and marking the seventh consecutive year that philanthropic gifts exceeded $100 million. Wed, 02 Oct 2013 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8264 Susan Mar 2013-10-02T00:00:00Z